Stockreport

Needham Hikes Centessa (CNTA) PT to $38 on High Potential for ORX-750 Trial Success and M&A Appeal [Yahoo! Finance]

Centessa Pharmaceuticals plc - American Depositary Shares  (CNTA) 
PDF the firm's price target on Centessa to $38 from $35 with a Buy rating on the shares. Needham suggested that Centessa's stock momentum is poised to persist through 2026 d [Read more]